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ABSTRACT Cerebral malaria (CM) is a major contributor to malaria deaths, but its pathophysiology is not well understood.
While sequestration of parasitized erythrocytes is thought to be critical, the roles of inflammation and coagulation are contro-
versial. In a large series of Malawian children hospitalized with CM, HIV coinfection was more prevalent than in pediatric popu-
lation estimates (15% versus 2%, P< 0.0001, chi-square test), with higher mortality than that seen in HIV-uninfected children
(23% versus 17%, P 0.0178, chi-square test). HIV-infected (HIV) children with autopsy-confirmed CMwere older than HIV-
uninfected children (median age, 99 months versus 32 months, P 0.0007, Mann-Whitney U test) and appeared to lack severe
immunosuppression. Because HIV infection is associated with dysregulated inflammation and platelet activation, we performed
immunohistochemistry analysis for monocytes, platelets, and neutrophils in brain tissue fromHIV and HIV-uninfected chil-
dren with fatal CM. Children with autopsy-confirmed CM had significantly (>9 times) more accumulations of intravascular
monocytes and platelets, but not neutrophils, than did children with nonmalarial causes of coma. The monocyte and platelet
accumulations were significantly (>2-fold) greater in HIV children than in HIV-uninfected children with autopsy-confirmed
CM. Our findings indicate that HIV is a risk factor for CM and for death from CM, independent of traditional measures of HIV
disease severity. Brain histopathology supports the hypotheses that inflammation and coagulation contribute to the pathogene-
sis of pediatric CM and that immune dysregulation in HIV children exacerbates the pathological features associated with CM.
IMPORTANCE There are nearly 1 million malaria deaths yearly, primarily in sub-Saharan African children. Cerebral malaria
(CM), marked by coma and sequestered malaria parasites in brain blood vessels, causes half of these deaths, although the mecha-
nisms causing coma and death are uncertain. Sub-Saharan Africa has a high HIV prevalence, with 3 million HIV-infected
(HIV) children, but the effects of HIV on CM pathogenesis andmortality are unknown. In a study of pediatric CM inMalawi,
HIV prevalence was high and CM-attributed mortality was higher in HIV than in HIV-uninfected children. Brain pathology in
children with fatal CMwas notable not only for sequestered malaria parasites but also for intravascular accumulations of mono-
cytes and platelets that were more severe in HIV children. Our findings raise the possibility that HIV children at risk for ma-
laria may benefit from targeted malaria prophylaxis and that adjunctive treatments targeting inflammation and/or coagulation
may improve CM outcomes.
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There are 1.2 billion people at high risk for malaria infectionworldwide. Plasmodium falciparum is the most virulent of the
malaria species that infect humans, and it is responsible for the
majority of morbidity and mortality related to malaria infection.
While malaria incidence and malaria-associated mortality have
decreased significantly over the past several years, the disease bur-
den is still high, with an estimated 198 million malaria infections
and 584,000 malaria-associated deaths in 2013 (1). The majority
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of these deaths are due to cerebral malaria (CM) and severe ma-
larial anemia (SMA) in sub-Saharan African children, in whom 1
in 7 deaths are due to malaria (1–3).
Human immunodeficiency virus type 1 (HIV) also dispropor-
tionally affects sub-Saharan Africa. There are 35.3 million people
livingwithHIVworldwide, with 25million in sub-SaharanAfrica,
including 3million children (4).Despite the geographic overlap of
areas heavily affected by malaria and HIV and the presumed like-
lihood of widespread HIV-malaria coinfection, the effect of coin-
fection on disease pathogenesis and outcome has only recently
received attention, andmost studies have not examined the effects
of HIV coinfection in children with severe malaria.
Initial observational studies of HIV and P. falciparum coinfec-
tion from the late 1980s and early 1990s found no significant dif-
ferences in prevalence or severity of malaria disease (5–8). By the
late 1990s, HIV infectionwas found to negatively affect a pregnant
woman’s ability to controlP. falciparum parasitemia and placental
infection (9–12). More-recent studies on children and nonpreg-
nant adults in both endemic malaria transmission and sporadic
malaria transmission zones have shown that HIV infection is as-
sociated with more frequent and more severe P. falciparum infec-
tion (13–18), and this increased incidence of symptomatic and
severe malaria is inversely related to CD4 T lymphocyte counts
(19–21). The mechanisms behind these associations are not fully
understood, and the impact of HIV infection on CM has been
largely unexplored.
The World Health Organization (WHO) defines CM as un-
arousable coma accompanied by asexual P. falciparum para-
sitemia with no other identifiable cause for coma (22). While CM
is a relatively rare complication of malaria, it accounts for roughly
half of all malaria deaths (23). CM predominantly affects children
younger than 5 years living in endemicmalaria transmission zones
and, less commonly, people of all ages living in meso-endemic
transmission zones (24). Death from CM is rapid, and the case
fatality rate is 15 to 20% even among patients receiving appropri-
ate treatment (25, 26). Intravenous (i.v.) artesunate treatment
may improve survival (27).
The pathophysiology of CM is controversial and may differ
between children and adults, but sequestration of parasites in the
brainmicrovasculature is a characteristic feature (28, 29). There is
scant evidence of recruitment of inflammatory cells to intravascu-
lar or extravascular sites in adult CM (30), but monocytes and
platelets have been implicated in the pathogenesis of pediatric and
murine experimental CM and in placental malaria (28, 31–33).
Chronic HIV infection is associated with expansion of monocyte
subsets andplatelet activation, leading tomonocyte activation and
formation of circulating monocyte-platelet complexes (34–36).
This dysregulation of platelets and monocytes persists even with
effective antiretroviral therapy (ART) and is linked with a variety
of conditions, includingHIV-associated neurocognitive disorders
(HAND) (34, 35, 37).
In an ongoing study of the clinicopathological correlates of
pediatric CM based in Blantyre, Malawi, we enrolled3,000 sub-
jects and completed 103 autopsies of children with clinically de-
fined fatal CM and children dying with nonmalarial causes of
coma.We found 3 patterns of brain pathology in childrenmeeting
WHOclinical criteria for CMprior to death: intravascular seques-
tered parasites with no parenchymal changes (termed CM1); in-
travascular sequestered parasites and parenchymal changes, in-
cluding ring hemorrhages (termed CM2); and no pathology
suggestive of CM, with a nonmalarial anatomic cause of death
identified from autopsy (termed CM3) (28, 38). CM is a clinical
diagnosis that may be incorrect in a quarter of children meeting
existing clinical criteria. Adding retinopathy to the criteria im-
proves specificity for identifying autopsy-confirmed CM (CM1
and CM2) (39).
Malawi has a population of 15.9 million, half of whom are
15 years old, and the entire population is at risk formalaria. The
average age of children presenting with CM is 3.5 years, consistent
with Malawi’s hyperendemic malaria transmission (3, 40). The
HIV prevalence is 10% in the adult population and is estimated to
be 2.5% in children (4). Before ART was widely available in
Malawi, themajority of childrenwith perinatalHIV infection died
before age 3 (41).
Because of the important role that monocytes and platelets
play in HIV-associated inflammation, and the high rate of HIV
infection in children previously enrolled, we hypothesized that
HIV coinfection exacerbates host factors that contribute to the
pathogenesis of CM. We retrospectively compared autopsy-
derived samples and clinical data from HIV-seropositive (HIV)
and HIV-seronegative (HIV-uninfected) children with fatal CM
to identify differences or similarities in presentation and pathol-
ogy.
RESULTS
HIV prevalence was higher than expected and conferred higher
mortality in CMpatients.During the period of the autopsy study
(1996 to 2010), 2,464 children were admitted to the Paediatric
Research Ward. Of these, 2,009 (81%) had HIV antibody testing
(Fig. 1a; see also Fig. S1 in the supplemental material). HIV prev-
alence was 14.5% in children enrolled in the cohort and 2% in
Malawi pediatric population estimates (odds ratio [OR] 8.338;
95% confidence interval [CI], 7.364 to 9.441; P  0.0001). Mor-
tality was 23.3% in HIV children and 17.5% in HIV-uninfected
children (OR  1.433; 95% CI, 1.063 to 1.932; P  0.0178).
Twenty percent of autopsy cases were HIV (19/96 children with
definitive HIV test results). HIV serostatus was associated with
CM brain pathology classification: 58% of children with the CM1
pathology pattern were HIV compared with 18% of the CM2
pathology group (OR 6.6; 95% CI, 1.614 to 26.99; P 0.0095).
Forty out of 52 (77%) autopsy-confirmed CM cases had the CM2
pathology pattern. HIV children were split equally between the
CM1 and CM2 pathology patterns (50%, or 7, had the CM1 pat-
tern), whereas 33 of 38 (87%) HIV-uninfected children had the
CM2 pattern.
HIV-infected children with CM were older than HIV-
uninfected children and were not severely immunocompro-
mised. To define pathological features that might distinguish
HIV-associated CM, we performed a blinded histopathological
study on a subset of 30 subjects from the autopsy series (Fig. 1b;
see also Fig. S2 in the supplemental material). Clinical character-
istics of the 96 autopsy subjects with definitive HIV testing (72
with clinically definedCMand 24with nonmalarial cause of coma
or indeterminate cause of death; Table 1) and clinical characteris-
tics of the 30-patient subset (see Table S1) were similar.
Among children who had a dilated retinal exam, all 41 (100%)
children with autopsy-confirmed CM (CM1 and CM2) had evi-
dence of malarial retinopathy, whereas 2 of the 15 (13.3%) chil-
dren with CM3 and 5 of the 22 (22.7%) children with nonmalarial
causes of coma had signs of retinopathy (P  0.0001, chi-square
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test). The same relationship between retinopathy and autopsy-
confirmed CM was true for the subset of 30 patients (P 0.0001,
chi-square test). In both the entire autopsy series and the subset of
30 patients with immunohistochemistry analysis, HIV children
with autopsy-confirmed CM were significantly older than HIV-
uninfected children (CM1 and CM2 groups combined; median
age, 84months versus 26.5months [P 0.0002] and 99.5months
versus 32months, respectively [P 0.0007;Mann-WhitneyU test
for both]) (Fig. 1c and Table 1; see also Fig. S3 in the supplemental
material). Ten of the 14 HIV children with autopsy-confirmed
CMwere5 years old (71%), whereas 5 of the 38HIV-uninfected
children with autopsy-confirmed CM were 5 years old (13%).
Higher peripheral platelet counts were noted in HIV than in
HIV-uninfected children with autopsy-confirmed CM in the en-
tire cohort (P  0.01) and the subset of 30 patients (P  0.04,
Mann-Whitney U test for both) (Table 1; see also Table S1 and
Fig. S3). There were no differences in gender, body mass index,
coma duration, fever duration, or admission values for peripheral
parasitemia, white blood cell count, or coma score in children
with clinically defined CM (Table 1; see also Table S1 and Fig. S3).
CM1 and CM2 subjects had similar hematocrit values, regardless
of HIV status (Table 1; see also Table S1).
No childwas known to beHIVprior to study enrollment, and
none was receiving ART. CD4 T lymphocyte quantification was
not performed at study enrollment because, during the early years
of the study, ART was not available in Malawi. Total white blood
cell count and total lymphocyte count did not differ between
HIV andHIV-uninfected children in the entire autopsy series or
in the immunohistochemistry subset of 30 patients (Table 1; see
also Fig. S3 and Table S1 in the supplemental material). Clinical
staging using WHO criteria for HIV severity from chart review,
including lymphocyte count, autopsy findings, and weight-for-
height z score, identified three out of 14 HIV children with
autopsy-confirmed CM with stage 3 or 4 HIV, considered ad-
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FIG 1 Features of HIV and HIV-uninfected autopsy subjects. (a) Classification of pathology pattern and HIV status among autopsy subjects. Twenty percent
of autopsy subjects were HIV, compared to 15% in the larger study group. CM cases were defined as in the work of Taylor et al. (38): CM1, autopsy-confirmed
cerebral malaria cases with sequestered parasites and no perivascular changes in brain pathology; CM2, autopsy-confirmed cerebral malaria cases with seques-
tered parasites and perivascular hemorrhages in brain pathology; CM3, clinically defined CM cases with no pathological evidence to suggest CM; andCOC, cases
with a nonmalarial cause of coma. Fifty-eight percent (7/12) of cases with the CM1 pathology pattern wereHIV. OneHIVCM1 patient aged 6months, whose
HIV-1 status could not be confirmed, was censored (including this patient, 8 of 13 CM1 patients were HIV). HIV prevalence is estimated to be 2% inMalawian
children. (b) Diagram of HIV status and brain pathology patterns of patients evaluated by immunohistochemistry. Thirty patients from the autopsy series were
studied in a blinded immunohistochemistry study. The groups comprised 10 CM1 (5 HIV and 5 HIV-uninfected), 10 CM2 (5 HIV and 5 HIV-uninfected),
and 10 CM3/COC (5 HIV and 5 HIV-uninfected) patients. Because there was only 1 HIV patient with a CM3 diagnosis, the HIV group included both CM3
and COC, whereas the HIV-uninfected group members all had a histopathological CM3 classification. (c) Age differences in children who underwent autopsy.
Horizontal bars and numerical values are medians. Among children with autopsy-confirmed CM (CM1 and CM2), HIV children were significantly older than
HIV-uninfected children. *, P 0.007 by Mann-Whitney U test; NS, not significant. The age distributions of CM1 and CM2 groups are shown in Fig. S3 in the
supplemental material. (d) HIV clinical staging of children with autopsy-confirmed CM. Chart review identified 11 out of 14 HIV children withWHO stage 1
or 2 HIV, indicating mild disease. The 3 children with severe disease met criteria for WHO stage 3 or 4 based on weight-for-height z score.
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vanced disease (Fig. 1d; see also Fig. S3). The children with stage
3/4 HIV were classified as such because of low weight-for-height
z scores, which were not significantly different betweenHIV and
HIV-uninfected children. Four out of five HIV children with
nonmalarial causes of death had stage 3/4 HIV, including dissem-
inated tuberculosis, meningitis, and complicated pneumonia.
Analysis of archived frozen plasma by real-time PCR of HIV
children (n 14 in total, 12 of whom were included in the subset
of 30) confirmed HIV infection in all samples, with a geometric
mean of 158,691 or 5.172 log10 copies/ml and an interquartile
range (IQR) of 69,285 to 488,520 or 4.825 to 5.673 log10 copies/ml.
There was no correlation between HIV load and white blood cell
count or lymphocyte count.
Pathology from complete autopsy for HIV children with
autopsy-confirmed CM did not identify AIDS-defining condi-
tions (e.g., Pneumocystis pneumonia, Kaposi sarcoma, or central
nervous system [CNS] lymphoma). Eleven of 96 autopsy cases
with lung pathology analysis had lymphoid interstitial pneumo-
nitis (LIP), eight of whom were HIV. All eight had autopsy-
confirmed CM, whereas only one of the three HIV-uninfected
children with LIP had autopsy-confirmed CM. Other diagnoses
included subdural hematoma and pneumonia with pulmonary
edema and diffuse alveolar damage. Clinically symptomatic LIP
with radiographic findings of reticulonodular infiltrates consti-
tutes a WHO stage 3 HIV diagnosis. None of the HIV children
had preceding respiratory complaints, and none with available
oxygen saturation data were hypoxic at initial hospitalization.
Fatal CM was associated with intravascular monocyte se-
questration thatwas greater inHIV-infected subjects.Examina-
tion of hematoxylin-and-eosin (H&E)-stained brain sections sug-
gested that cells other than parasitized red blood cells contributed
to intravascular pathology (see Fig. S4 in the supplemental mate-
rial), so we performed immunohistochemistry staining to charac-
terize these cells. Ionized calcium binding adapter molecule 1
TABLE 1 Clinical features of the entire autopsy cohorta
Clinical feature
Value for CM type and HIV status (n):
P value by
ANOVA or
chi-square testm
CM1 CM2
CM3; HIV
(n 1),
HIV (n 19)
Other or
indeterminate
cause of death;
HIV (n 4),
HIV/unknown
(n 26)HIV (n 7) HIV (n 5) HIV (n 7) HIV (n 33)
Age (mo) 79 (41, 103) 44 (26, 67.5) 96 (37, 144) 26 (18, 40.5) 28 (18.75, 47.75) 34.5 (19, 60.75) 0.006
Sex (% female) 71.4 80 42.9 42.4 25 60 NS
Admission coma
scoreb
1 1 1 1 1 1 NS
Retinopathy
(% positive)c
100 100 100 100 13.3 22.7 0.0001
Body mass index
(kg/m2)d
15.5 (14.6, 16.4) 13.6 (12.5, 15.7) 15.1 (14, 15.4) 14.4 (13.4, 15.3) 15.2 (13.75, 17.8) 14.5 (12.9, 16.3) NS
Total WBC (103/l)e 14.5 (12.1, 17.1) 11.2 (7.3, 15.7) 13.2 (10.9, 19.3) 12.4 (9.1, 21.5) 13.4 (10.5, 23.95) 16.1 (10.7, 23.1) NS
Lymphocyte count
(103/l)f
2.4 (1.5, 5.1) 2.3 (2, 5.5) 2.7 (1.5, 5.3) 5.3 (2.2, 7.8) 2.9 (2.5, 11.9) 3.8 (2.4, 5.2) NS
Monocyte count
(103/l)g
0.7 (0.1, 1.7) 1 (0.8, 2.5) 1.1 (0.5, 2.4) 1.7 (0.6, 2) 0.6 (0.3, 1.3) 1.2 (0.8, 3.3) NS
Parasitemia (103/l)h 98.3 (48.2, 324.8) 49.2 (5.1, 717.6) 56.4 (28.8, 308.7) 45.3 (7.5, 433.3) 13.6 (0.9, 147.6) (0, 0.3) NS (excluding
last column)
Hematocrit (%)i 22 (17, 35) 29 (22.5, 32) 21 (17, 26) 20 (12.3, 22.7) 31 (20.7, 36) 24.8 (7.8, 30.3) 0.02
Platelet count (103/l)j 74.4 (36, 144) 49.4 (31.5, 87.6) 117.4 (42.7, 351.5) 45.2 (26, 73) 155.8 (123, 276) 169.2 (70, 370) 0.0001 (excluding
last column)
Coma duration (h)k 19 (10.3, 33) 25 (13, 34) 28 (24, 43) 26 (14, 37) 17 (8, 30) 13.5 (8.3, 65.7) NS
Duration of illness (h)l 39.5 (24.7, 59) 35 (30, 158.5) 48 (36, 56) 79 (55.5, 106) 32 (19, 54) 71 (29.5, 144) 0.01
a Clinical characteristics of children who underwent autopsy for clinically defined CM or coma of other cause. Continuous variables are shown as medians with 25th and 75th
percentiles in parentheses, except for parasitemia and platelet counts, values for which are geometric means with 25th and 75th percentiles.
b Admission coma score, n 100 (n 28 for other/indeterminate cause of death).
c Retinopathy, n 78 (n 6 for CM1 HIV, n 6 for CM2 HIV, n 4 for CM1 HIV, n 25 for CM2 HIV, n 15 for CM3, n 22 for other/indeterminate cause of
death).
d Body mass index, n 100 (n 32 for CM2 HIV, n 29 for other/indeterminate case of death).
e Total white blood cells (WBC), n 85 (n 6 for CM2 HIV, n 29 for CM2 HIV, n 13 for CM3, n 25 for other/indeterminate cause of death).
f Lymphocyte count, n 48 (n 5 for CM1 HIV, n 4 for CM1 HIV, n 4 for CM2 HIV, n 14 for CM2 HIV, n 10 for CM3, n 11 for other/indeterminate cause of
death).
g Monocyte count, n 39 (n 4 for CM1 HIV and CM2 HIV, n 3 for CM1 HIV, n 11 for CM2 HIV, n 8 for CM3, n 7 for other/indeterminate cause of death).
h Parasitemia, n 100 (n 28 for other/indeterminate cause of death).
i Hematocrit, n 101 (n 19 for CM3).
j Platelet count, n 81 (n 6 for CM2 HIV, n 25 for CM2 HIV, n 19 for CM3, n 19 for other/indeterminate cause of death).
k Coma duration, n 82 (n 6 for CM1 HIV, n 5 for CM2 HIV, n 31 for CM2 HIV, n 17 for CM3, n 18 for other/indeterminate cause of death).
l Duration of illness, n 98 (n 6 for CM1 HIV, n 18 for CM3, n 29 for other/indeterminate cause of death). Duration of illness was determined by combining the duration
of fever with duration of coma. Note that when data from HIV/HIV patients are merged and CM1 is compared with CM2, CM2 has a significantly longer duration of illness.
m Differences between groups were analyzed by 1-way analysis of variance (ANOVA) (normal data) or Kruskal-Wallis test (nonnormal data) for continuous variables and by chi-
square test for dichotomous variables. NS, not significant.
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(Iba1) is specific for the monocyte lineage and is commonly used
as amarker formonocytes,macrophages, andmicroglia in immu-
nohistochemical studies of inflammation in the brain (42). Iba1
staining revealed activated microglia surrounding microhemor-
rhages in CM2 sections (Fig. 2a, top right). In several CM1 and
CM2 (but not CM3) sections, blood vessels appeared packed with
Iba1 cells containing hemozoin, indicating monocytes that had
phagocytosed late-stage parasites. The degree to which these
monocytes were present did not always correspond to the amount
of sequestered parasites in the brain, as some subjects had blood
vessels filled with parasites but with few monocytes (Fig. 2a, bot-
tom left), while others had both parasites and many monocytes
(Fig. 2a, bottom middle). Monocytes lined the inner surface of
large-caliber vessels, appearing to adhere to the endothelium
(Fig. 2a, bottom right).
To further evaluate the association between monocytes and CM,
we performed blinded quantification of intravascular monocytes by
measuring the areas of 50 blood vessels in cross section as well as the
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FIG 2 Immunohistochemistry of brain tissue for microglia and monocytes. (a) Micrographs (400) of brain sections stained with H&E (top left) and
immunohistochemically labeled for Iba1 (top right and 3 bottom panels). Brown color indicates the presence of Iba1. (Top left) Ring hemorrhage in close
proximity to a blood vessel; (top right) microglia surrounding a ring hemorrhage; (bottom left) blood vessel packed with parasites (denoted by black pigment of
hemozoin) with scant monocytes; (bottom middle) blood vessel packed with monocytes containing hemozoin; (bottom right) large vessel with monocytes
containing hemozoin lining the endovascular surface. (b) Comparison of the proportions of blood vessel surface areas with Iba1 staining. Values are shown as
medians with interquartile ranges. COC, children with an obvious nonmalarial cause of coma. *, P 0.0001 byMann-Whitney U test. Autopsy-confirmed CM
cases (CM1 and CM2) have more intravascular monocytes than do cases with coma of other cause (CM3 and COC). Among cases of autopsy-confirmed CM,
HIV children have more intravascular monocytes than do children not infected with HIV.
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areas of Iba1 cells in each vessel, calculating the proportions of
Iba1 blood vessel surface areas (ImageJ software). Autopsy-
confirmed CM cases had significantly more (greater than 600 times
more) brain intravascular monocytes than did children with other
causes of death (CM3 and nonmalarial causes of coma) (Fig. 2b).
Among autopsy-confirmed CM cases, HIV children had 1.9 times
more intravascularmonocytes thandidHIV-uninfected subjects. In-
travascular monocytes did not correlate with coma or illness dura-
tion, peripheral monocyte counts, or the monocyte-lymphocyte ra-
tio, a potential marker for clinical malaria (43).
Fatal CMwas associatedwith intravascular platelet accumu-
lation that was greater in HIV-infected subjects but was not as-
sociated with neutrophil accumulation. Evaluation of tissue sec-
tions labeled for the platelet marker CD61 identified a range of
intravascular platelet findings; some subjects had scant intravas-
cular platelets, and others had significant intravascular staining,
suggesting the presence of thrombus (Fig. 3a, top left and right,
respectively). Quantification of intravascular platelets using Im-
ageJ software identified an 8.8-times-greater proportion of
CD61 blood vessel surface area in children with autopsy-
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FIG 3 Immunohistochemistry of brain tissue for platelets and neutrophils. (a) Micrographs (400) of brain sections labeled for CD61 (top left and right) and
neutrophil elastase (bottom left and right). Brown color indicates the presence ofCD61or neutrophil elastase. COC, caseswith a nonmalarial cause of coma. (Top
left) Blood vessel filled with platelets and parasites (denoted by black pigment of hemozoin); (top right) blood vessel with scant platelets; (bottom left) blood
vessel with one intravascular neutrophil at top and intravascular hemozoin at bottom, from a child with autopsy-confirmed CM; (bottom right) multiple intra-
and perivascular neutrophils, from a child with bacterial meningitis. (b) Comparison of the proportions of blood vessel surface areas with CD61 staining. Values
are shown asmedians with interquartile ranges. *, P 0.0001 byMann-Whitney U test. Autopsy-confirmed CM cases (CM1 and CM2) havemore intravascular
platelets than do caseswith comaof other causes (CM3 andCOC). Among cases of autopsy-confirmedCM,HIV children havemore intravascular platelets than
do children not infectedwithHIV. (c) Comparison of the proportions of blood vessel surface areaswith neutrophil elastase staining. Values are shown asmedians
with interquartile ranges. *, P 0.0001 by Mann-Whitney U test. Autopsy-confirmed CM cases (CM1 and CM2) have low levels of intravascular neutrophils,
with no difference based on HIV status. HIV-uninfected CM3 cases have more intravascular neutrophils than do other groups, possibly because three patients
had bacterial infection with meningeal involvement or meningoencephalitis diagnosed at autopsy.
Hochman et al.
6 ® mbio.asm.org September/October 2015 Volume 6 Issue 5 e01390-15
confirmed CM than in children with other causes of death (CM3
and nonmalarial cause of coma) (Fig. 3b). Among autopsy-
confirmed CM cases, HIV children had 4.5 times more intravas-
cular platelets than did HIV-uninfected children. The proportion
of intravascular platelet staining did not correlate with peripheral
platelet counts or with duration of illness.
Becausemalaria affects neutrophil function (44), we looked for
evidence of neutrophil recruitment to the vasculature during CM.
Immunohistochemistry analysis for neutrophil elastase (NE; a
serine protease secreted by neutrophils during inflammation)
identified scattered intravascular neutrophils and areas of perivas-
cular degranulation (Fig. 3a, bottom). There was no evidence of
small-caliber vessels filled with neutrophils or of neutrophils ad-
herent to the walls of larger vessels, as was seen with monocytes.
Quantification of intravascular NE staining using ImageJ software
found no differences in intravascular neutrophils based on HIV
serostatus or pathology pattern in children with autopsy-
confirmed CM (Fig. 3c). HIV-uninfected children with the CM3
pattern had significantly more intravascular neutrophils than did
any other group. Three of these children had pathological evi-
dence ofmeningitis ormeningoencephalitis, processes that lead to
recruitment and accumulation of neutrophils in the brain.
We detected no HIV-1 p24 with immunohistochemistry anal-
ysis of brain sections in any of the 30 autopsy subjects, regardless
of HIV serostatus (data not shown), consistent with earlier brain
pathology studies of HIV children (45). HIV-1 p24 was detected
in positive controls (tonsil and brain tissue from U.S. adults with
HIV encephalitis and fixed HIV-infected microglia from in vitro
culture).
Fatal CM was associated with high parasite burdens that
were greater in HIV-infected subjects. Peripheral parasitemia
was not predictive of CM (Table 1), but differences in brain par-
asite burden were seen in the proportion of blood vessel surface
area covered by hemozoin (Fig. 4a). Autopsy-confirmedCMcases
had significantly more brain intravascular hemozoin than did
cases with another cause of death (CM3 and obvious nonmalarial
cause of coma), and among autopsy-confirmed CM cases, HIV
children had 1.8 times more intravascular hemozoin than did
HIV-uninfected children. Intravascular monocytes and intravas-
cular platelets correlated with hemozoin measurements (Spear-
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FIG 4 Comparison of parasite burden using intravascular hemozoin area, plasma PfHRP2, and percentage of parasitized vessels. (a) Comparison of the
proportions of intravascular hemozoin surface areas. Values are shown as medians with interquartile ranges. COC, cases with an obvious nonmalarial cause of
coma. *, P 0.0001 by Mann-Whitney U test. Autopsy-confirmed CM cases (CM1 and CM2) have more intravascular hemozoin than do cases with coma of
other causes. Among cases of autopsy-confirmed CM, HIV children have more intravascular hemozoin than do children not infected with HIV. (b) Compar-
ison of plasma PfHRP2 levels. Plasma PfHRP2 levels were measured by enzyme-linked immunosorbent assay from archived plasma samples. Values are shown
as geometric means. Autopsy-confirmed CM cases (CM1 and CM2) had higher PfHRP2 levels in plasma than did parasitemic cases with coma of other causes
(CM3 and COC; P 0.02, 1-way analysis of variance). No difference was detected based on HIV serostatus. Twenty-six children had PfHRP2 levels measured.
Only one of theHIVCM3/COCchildren had parasitemia andPfHRP2 testing, and so this groupwas excluded from statistical analysis. (c) Spearman correlation
of plasma PfHRP2 with hemozoin surface area measurements. PfHRP2 plasma levels (n  26) positively correlate with hemozoin measurements from brain
pathology (Spearman rho 0.558, P 0.003). (d) Spearman correlation of brain blood vessels parasitized (VPC) with hemozoin surface area measurements.
Percent counts of parasitized vessels positively correlate with hemozoin measurements from brain pathology (Spearman rho 0.694, P 0.0001).
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man rho 0.8274, P 0.0001, for monocytes; Spearman rho
0.6793, P 0.0001, for platelets).
P. falciparum histidine-rich protein 2 (PfHRP2) is used as an
antigen inmalaria rapid diagnostic tests.More PfHRP2 is released
as the parasite matures within the erythrocyte, with the largest
amount being released at schizont rupture, when parasites are
sequestered in deep tissues such as the brain (46). Quantification
of PfHRP2 can help to distinguish uncomplicated malaria from
severe malaria (47) and may act as a biomarker for sequestered
parasite burden. We compared plasma PfHRP2 levels in the au-
topsy study patients with immunohistochemistry results analyzed
here, excluding the HIV CM3/nonmalarial-cause-of-coma
group because only 1 out of 5 children had parasitemia and
PfHRP2 testing. The HIV-uninfected CM3 group had signifi-
cantly less PfHRP2 than did childrenwith autopsy-confirmedCM
(Fig. 4b). Similar differences were noted between children with
and without malarial retinopathy in the larger cohort (48). There
was no difference in PfHRP2 levels between CM1 and CM2
groups regardless of HIV status. Brain intravascular hemozoin
measurements using ImageJ correlated with plasma PfHRP2 lev-
els (Fig. 4c) and with the percentage of blood vessels containing
parasites (Fig. 4d). Neither PfHRP2, hemozoin, nor the percent-
age of vessels parasitized correlated with fever or coma duration.
DISCUSSION
We have identified a unique and pervasive pathology pattern in
pediatric CM, marked by intravascular monocytes and platelets,
which is more severe in HIV children. This has not been previ-
ously described in adult CM studies (49) but has been noted in the
rodent experimental CM (ECM) model (50). We previously
showed that children with fatal CMhavemore brain intravascular
platelets than do children with fatal SMA or nonmalarial cause of
coma (51). Intravascularmonocytes have also been noted in stud-
ies of CM (28, 52), but they have never been quantified or corre-
lated with intravascular platelets. ECM is not universally accepted
as a model for human CM (53), in part because sequestered par-
asitized erythrocytes are not as prominent as in human CM, but
there is growing evidence that infected erythrocytes do become
sequestered and are necessary for ECM to develop (54–57).
Understanding how HIV exacerbates CMmay provide insight
into the pathological processes underlying CM in all children.
HIV infection is associated with platelet activation and the forma-
tion of monocyte-platelet complexes, and these complexes are
more adherent to the vascular endothelium than are monocytes
alone (36). In our histologic analysis,monocytes appear to actively
migrate to sites of malaria sequestration and accumulate in brain
microvasculature with infected erythrocytes. HIV infection may
further enhance this phenomenon, through production of che-
moattractants such asCCL2 in the brain, increased responsiveness
to chemoattractants in HIV-infected monocytes, and enhanced
binding of monocytes to the endothelial surface (34, 35).
Monocytes and platelets contribute to other severe malaria
syndromes, including placental malaria (33, 58), a syndrome
more common in HIVmothers (12, 33). Circulating hemozoin-
containing monocytes are associated with malarial anemia in
HIV children (59). Platelets can act as a bridge between parasit-
ized red blood cells and brain endothelial cells in vitro by upregu-
lating endothelial CD36 (60), a receptor that is also involved in the
in vitro clumping of platelets and parasitized red blood cells from
adults and children with severe malaria (61, 62).
Severe malaria, particularly CM, is associated with higher par-
asite burdens measured by plasma PfHRP2 than are found in un-
complicated malaria (63). We found higher parasite burdens,
measured by surface area of intravascular hemozoin, in autopsy-
confirmed CM cases than in parasitemic children with nonma-
larial cause of coma, and also in HIV than in HIV-uninfected
children with fatal CM. Similar differences were noted using
plasma PfHRP2 measurements in a study of HIV and severe ma-
laria in Mozambique (64). The correlation between brain intra-
vascular hemozoin, circulating PfHRP2, and percentage of vessels
parasitized reinforces the utility of PfHRP2 quantification as a
biomarker for total parasite burden.
Based on population estimates of pediatric HIV prevalence in
Malawi, HIVMalawian children are at increased risk for devel-
oping CM. Risk of symptomatic malaria has been linked to low
CD4 T lymphocyte counts (65), but in our study, the increased
risk of CM was not due to severe immunosuppression as seen in
advanced AIDS. HIV infection may impair clearance of malaria
parasites by monocytes and macrophages independent of T cells,
resulting in an increased parasite burden and therefore a greater
likelihood of developing CM.
Within the autopsy series, HIV children were significantly
older than HIV-uninfected children. This age disparity was previ-
ously noted in the larger clinicopathological study (16) and spe-
cifically in children with malarial retinopathy (E. Mbale, C. A.
Moxon, M. E. Molyneux, and T. E. Taylor, unpublished data), as
well as in children with severe malaria in Mozambique (64) and
Kenya (66). Untreated perinatally acquired HIV confers high
mortality during infancy (41), and thus, these older HIV chil-
dren presenting with CM are drawn from a survivor minority.
Although clinical parameters did not indicate severe immune sup-
pression, some had pathological evidence of immune dysregula-
tion; eight of 14 (57%) HIV children with CM had lung pathol-
ogy with LIP, a lymphoproliferation associated with slower
progression of HIV disease in perinatally infected children (67).
Children with clinically symptomatic LIP have greater immune
dysregulation than do age-matched HIV children without LIP
(68).
Older age at presentation with severe malaria among HIV
childrenmay be due to loss of acquiredmalarial immunity as HIV
progressively weakens the immune system; alternatively, effective
antibodies to variant antigensmay not develop because of B cell or
memory cell dysfunction. These children may represent a pediat-
ric population similar to adults with slowly progressive HIV dis-
ease, who often have evidence of ongoing chronic inflammation
(37, 69). Future studies evaluating malaria antibody response in
HIV adults and perinatally infected or exposed children may
identify high-risk groups who would benefit from targeted ma-
laria chemoprophylaxis.
While ART likely improves B cell immunity, lingering immune
dysfunction associated with monocyte and endothelial activa-
tion persists in HIV individuals even with viral suppression.
Therefore, the optimal management of HIV children at risk for
malaria remains unknown, particularly since widespread P. falci-
parum resistance may limit the antimalarial efficacy of
trimethoprim-sulfamethoxazole, recommended by the WHO for
prophylaxis in all HIV adults and children (70). Although fur-
ther study is needed, in recent malaria seasons, increasing num-
bers ofHIV childrenwithCMreceivingARThave been admitted
to the Paediatric ResearchWard while the HIV prevalence of hos-
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pitalized children with CM has not changed, suggesting that ART
does not reduce the risk of severe malaria (K. B. Seydel and T. E.
Taylor, unpublished data).
Previous studies have demonstrated that the loss of the endo-
thelial protein C receptor (EPCR) is associated with foci of local-
ized microvascular coagulation in CM (71), and EPCR has now
been identified as the major endothelial receptor for Plasmodium
falciparum erythrocyte membrane protein 1 (PfEMP1) subtypes
linked to severe malaria, including CM (72). Taken together, we
can postulate a model in which infected erythrocytes displaying
virulent PfEMP1 subtypes adhere to endothelial cells, resulting in
activation of endothelium with conversion of the endothelium
from an anticoagulant to procoagulant state. In many pathologi-
cal states, including HIV infection, endothelial dysfunction is as-
sociated with platelet activation, adhesion to endothelium,
clumping, and complex formation withmonocytes (56). Both en-
dothelial activation and platelet activation upregulate expression
of endothelial adhesion molecules and release of inflammatory
cytokines and chemokines (56). We have reported that brain
edema is associatedwith death in CM (73), but themechanism for
these clinical findings is not yet understood. HIV infection likely
exacerbates endothelial dysfunction in response to parasitized
erythrocytes.
An inherent limitation of any autopsy study and most human
clinical studies is that while they can identify correlations sugges-
tive of causality, they cannot be used to deduce causal relation-
ships. We describe a significant association of intravascular
monocytes andplatelets (and sequestered parasites)with pediatric
CM. It is notable that our human histopathology findings support
some observations reported in ECM, a rodent model whose rele-
vance to human pathophysiology is uncertain (53). If ECM stud-
ies are combined with human blood-brain barrier in vitro studies
utilizing parasitized erythrocytes, peripheral blood mononuclear
cells, and platelets (68), it may be possible to identify mechanisms
by whichmonocytes and platelets contribute to CMpathogenesis.
We now show that fatal pediatric CM is associated with intra-
vascular accumulation of infected erythrocytes, monocytes, and
platelets that is qualitatively similar, but more pronounced, in
those children with CM who are HIV. Further investigation of
how HIV infection affects the microvasculature of children with
CMmay illuminate how brain microvascular coagulation and in-
flammation contribute to brain edema and pediatric CM patho-
genesis.
MATERIALS AND METHODS
Clinicopathological study and consent. The institutional review boards
(IRBs) of the University of Malawi College of Medicine, the Albert Ein-
stein College of Medicine, Michigan State University, and the Brigham
and Women’s Hospital approved all aspects of this study, including in-
formed written consent from parents/guardians.
Children aged 6 months to 12 years presenting to Queen Elizabeth
Central Hospital (QECH) in Blantyre, Malawi, who met the CM clinical
case definition (peripheral P. falciparum parasitemia, a Blantyre coma
score of2 [unrousable coma], and no other identifiable cause for coma)
were treated in the Paediatric Research Ward and enrolled in an ongoing
observational study of malaria pathogenesis run by the Blantyre Malaria
Project (BMP) and the Malawi-Liverpool-Wellcome Trust Clinical Re-
search Programme (MLW) previously described (16, 38, 74). Blood cul-
tures and cerebrospinal fluid cultures were routinely obtained unless con-
traindicated. From 1996 to 2010, a study of the clinicopathological
correlates of fatal CM was pursued, and during that time, 2,464 children
were evaluated and 420 died (17%mortality). One hundred three autop-
sies were performed, constituting the largest controlled autopsy series of
CM to date. In the event of death, permission was requested from family
members for autopsy, where brain and other organs were sectioned and
fixed in 10% buffered formalin. We define “autopsy-confirmed CM” as
fatal clinically defined CM with sequestered parasitized erythrocytes in
20% of intracerebral microvessels and no other identifiable cause of
death (38).
Voluntary counseling and testing for HIV were incorporated into the
study in 2001. Plasma from autopsy cases not tested prior to death and
archived specimens from 1996 to 2000 were tested retrospectively with
IRB approval. All patients with clinically defined CMprior to autopsy had
HIV antibody testing. Six childrenwith another cause or an indeterminate
cause of death prior to autopsy were not tested for HIV. One child with
autopsy-confirmed CM had detectable HIV antibody but was 6 months
old with no sample available for confirmatory testing with HIV PCR and
was censored. Twenty of 96 autopsy cases with definitive testing were
HIV. All 14 HIV cases with archived plasma had quantifiable HIV
loads (Abbott m2000 system). The tissues analyzed in our study represent
a subset of the autopsy series, including 12 of the 14 HIV children with
archived plasma.
We analyzed temporal lobe brain tissue from 30 autopsy subjects: 10
patients with the CM1 pattern (P. falciparum sequestration with no pa-
renchymal changes), 10 patients with the CM2 pattern (P. falciparum
sequestration with parenchymal changes, including hemorrhage), and 10
patients with either the CM3 pattern (those who met the clinical case
definition of CM but for whom a nonmalarial cause of death was deter-
mined from autopsy) or a nonmalarial cause of coma prior to death. Five
from each group were HIV, determined by antibody-based test. These
cases were selected by D.A.M., who was not involved in immunohisto-
chemistry analysis, and matched by histopathology pattern and degree of
parasite sequestration (defined by percentage of parasitized vessels and
described in detail previously) (75). There were only five HIV-uninfected
CM1 cases andfiveHIVpatientswith a nonmalarial cause of death in the
entire autopsy series. ThisHIV group comprised oneHIVCM3patient
plus four HIV patients with a nonmalarial cause of death. The HIV-
uninfected subjects with nonmalarial causes of death were all CM3. These
patients were chosen so that peripheral parasitemia was comparable to
that in HIV-uninfected CM groups. The investigators who performed
immunohistochemistry and microscopic analysis (S.E.H., T.F.M., N.C.,
and S.L.) were blinded to all patient-related information, including histo-
pathology pattern,HIV antibody status, and the criteria used to pick cases.
A retrospective chart review was performed to identify clinical char-
acteristics and history used as criteria for WHO Clinical Staging of HIV/
AIDS in Infants and Children guidelines. Children were classified as stage
1/2 (mild disease) or stage 3/4 (if they met criteria for severe disease).
Pathological analysis of lung tissue. Lungs from 101 of 103 autopsies
were previously examined (76). Lung histology was graded on a scale of 0
to 3 by a single pathologist (R.O.W.) who was blinded to final anatomic
diagnosis and HIV status.
Immunohistochemistry analysis of temporal lobe tissue. Five-
micrometer sections of fixed, paraffin-embedded temporal lobe tissue
from 30 subjects who underwent autopsy were evaluated. Tissue slides
were labeled for HIV-1 p24, a capsid protein expressed during HIV rep-
lication; ionized calcium binding adapter molecule 1 (Iba1), a marker
specific for the monocyte lineage that is present in microglia, macro-
phages, and monocytes; CD61, a platelet glycoprotein; and neutrophil
elastase (NE), a serine protease in neutrophil granules that is released
during neutrophil activation.
Sections were deparaffinized and rehydrated in successive xylene and
alcohol solutions, boiled for antigen retrieval at 95°C for 20min in sodium
citrate buffer (Dako), treated with 3% H2O2 to block endogenous perox-
idase activity, and incubated with 10% normal goat or horse serum to
block nonspecific antibody binding. No antigen retrieval was performed
for NE.
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Immunohistochemistry labeling. Primary antibodies were (i) mouse
anti-HIV-1 p24 (IgG1; Dako), 1:10 concentration, 4-h incubation; (ii)
rabbit anti-Iba1 (polyclonal;Wako), 1:250 concentration, 1-h incubation;
(iii) mouse anti-CD61 IOPath (IgG1; clone SZ21; Beckman Coulter) un-
diluted, 2-h incubation; and (iv) mouse anti-neutrophil elastase (NE;
IgG1; clone NP57; Dako), 1:100 dilution, 2-h incubation. p24 and Iba1
antibody labeling was followed by incubation with an avidin-biotin com-
plex method kit (ABC Vectastain kit; Vector Labs) according to the man-
ufacturer’s instructions. CD61 and NE primary antibody labeling was
followed by incubation with anti-mouse micropolymer-linked secondary
antibody (ImmPRESS kit; Vector Labs) according to the manufacturer’s
instructions. Color was developed with diaminobenzidine (DAB), with
hematoxylin counterstaining. Positive controls for p24 and Iba1 included
paraffin-embedded brain tissue with a neuropathologic diagnosis of HIV
encephalitis, paraffin-embedded tonsil from HIV donors, and fixed
HIV-infected microglia from in vitro culture. Sections incubated with an
irrelevant mouse IgG1 antibody were used as negative controls for p24,
CD61, and NE. Sections incubated with an irrelevant polyclonal rabbit
antibody were used as negative controls for Iba1.
Quantification of intravascular monocytes, platelets, and neutro-
phils. Fifty to 100 high-power fields (hpf; 400) from each slide were
digitally photographed. ImageJ software was used to outline andmeasure
the total blood vessel area, the area of intravascular Iba1 staining, and the
area of intravascular hemozoin in 50 vessels from 50 hpf by setting thresh-
old values for DAB and hemozoin intensity. No distinction was made
between free hemozoin, intraerythrocytic hemozoin, and hemozoin
within monocytes. Measurements were conducted in duplicate by two
independent, blinded observers (S.E.H. and T.F.M.). Statistical analysis
for each observer was performed for each series with similar results, and
there was significant statistical correlation between individual patient val-
ues for each observer (see below). Results from one observer are shown in
the figures.
PfHRP2measurement. Enzyme-linked immunosorbent assay was per-
formed on archived frozen plasma, using plates precoated with anti-PfHRP2
antibody (Cellabs, Brookvale, Australia). Plasma was thawed, diluted 1:500,
and plated in duplicate along with a stock solution of recombinant PfHRP2.
The manufacturer’s protocol was followed with the exception of incubation
steps, which were carried out at 37°C in a humidified chamber. After sample
incubation, secondary conjugated antibody incubation, and addition of sub-
strate, plates were analyzed at an optical density at 450 nm (OD450). A stan-
dard curve was generated from wells containing recombinant PfHRP2, and
readings from diluted plasma samples were compared to this curve to calcu-
late PfHRP2 levels. Twenty-six out of 30 children in this autopsy series had
parasitemia and PfHRP2 testing.
Statistical analyses. Clinical data were analyzed using the Kruskal-
Wallis one-way analysis of variance and Mann-Whitney U test or un-
paired t test with Welch’s correction for continuous variables and the
chi-square test or Fisher’s exact test for dichotomous variables. Quantifi-
cation of intravascular hemozoin, monocytes, neutrophils, and platelets
was analyzed by Kruskal-Wallis one-way analysis of variance and by
Mann-Whitney U test. All applicable P values are two-tailed. Correlation
of ImageJmeasurements between observers was analyzed using Lin’s con-
cordance correlation coefficient (77). There was significant correlation of
Iba1 measurements (rho 0.727, P 0.001), CD61 measurements (rho
 0.859, P  0.001), and NE measurements (rho  0.652, P  0.001)
between observers. Analysis was performed using GraphPad Prism ver-
sion 6 and Stata version 12.0.
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